ArticleBiotechnology and bioengineering2023
αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform.
Jingru Che et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it